Nicholas Chronos, MD, FRCP, FACC, FESC, FAHA

Dr. Chronos serves as the Chief Scientific and Medical Officer of the Saint Joseph's Research Institute (SJRI) at Saint Joseph's Hospital in Atlanta, where he directs and concurrently oversees pre-clinical and clinical trials. Dr. Chronos practices Interventional Cardiology with the Atlanta Cardiology Group (at Saint Joseph's Hospital of Atlanta), is a distinguished Adjunct Professor of Cardiology and Medicine at Duke University and is a renowned faculty member and speaker at major medical conferences both nationally and internationally.

He is a Fellow of the Royal College of Physicians (London), the American College of Cardiology, the European Society of Cardiology and the American Heart Association. He received his Bachelors degree in Medicine and Surgery from the Royal Free Hospital School of Medicine in London in 1987, and subsequently trained in cardiology and interventional cardiology at the Royal Brompton National Heart and Lung Institute under the direction of Professors Ulrich Sigwart and Anthony Rickards.

In 1992, he was awarded the British Heart Foundation International Fellowship and furthered his research in Thrombosis and Interventional Cardiology at Emory University School of Medicine, under the direction of Spencer B. King, III, M.D. In 1997 he was named Director of Research at the Andreas Gruentzig Cardiovascular Center at Emory University Hospital.

In addition, Dr. Chronos has served on numerous committees at the National Institutes of Health as well as a Study Section Member and Chair for the Center for Scientific Review Cardiovascular Science and SBIR. In 2006, he became a member of the NIH Recombinant DNA Advisory Committee. He has served on the Data Safety Monitoring Board (ClinTrials Research), NIRVANA (Boston Scientific), and SCORES (Scimed Life Systems). Dr. Chronos currently serves as a Board Member on multiple Scientific Advisory Boards including METRONIC VASCULAR, BIOHEART Inc., SYMPHONY MEDICAL, VIACELL, ATLANTA BIOTECH NETWORK, ACTx, PROTEUS BIOMEDICAL, and CELTAXSYS.

Distinguished world-wide for his pioneering research in angiogenesis, Dr. Chronos was named Co-National Principal Investigator on the FIRST (Chiron Corporation) study, the largest human clinical trial of angiogenesis. Presently he serves as Principal Investigator for two large clinical trials that use autologous stem cells to repair damaged cardiac muscle. His prominent work on the MYOHEART (Myogenesis Heart Efficiency and Regeneration Trial) has received widespread media attention nationwide. He has also served on the Steering Committees for various scientific studies such as such as RFPMR (Boston Scientific), and TARGET (Merck & Co., Inc.).

To date, Dr. Chronos has published over two hundred peer-reviewed papers, over one hundred abstracts, and seventeen book chapters. His publications include articles in the Journal of the American College of Cardiology, Circulation, Heart and European Journal of Cardiology. He is an editorial consultant to the New England Journal of Medicine, British Heart Journal, Clinical Science, the Journal of the American College of Cardiology, Circulation, Heart, Atherosclerosis, Catheterization and Cardiovascular Interventions, Stent, Thrombosis Research, Cardiovascular Radiation Medicine, Journal of Stem Cells and Nature Medicine as well as other distinguished peer reviewed journals. He serves as Editorial Consultant to many of the aforementioned scientific publications.